5 questions facing gene therapy in 2023

Image credit: Danielle Ternes / BioPharma Dive. Article by Ned Pagliarulo. BioPharma Dive – January 12, 2023.

Sometime before the end of March, a person with the inherited blood disease beta thalassemia will receive an infusion containing hundreds of millions of their own stem cells. These cells will have just completed a round-trip journey to a drug manufacturing facility, where they’ll be equipped with a modified gene capable of fixing the patient’s condition. […]

Click here to view original web page at www.biopharmadive.com